SINGAPORE - Singapore Exchange (SGX) has revamped its foreign exchange (FX) and technology management teams following some ...
The provider of active live stem cell therapies is planning to raise $30 million. Read more at straitstimes.com.
Hosted on MSN1mon
SGX Group CEO on the exchange's IPO pipeline and business prioritiesLoh Boon Chye, CEO of SGX Group says the pipeline and sentiment for IPOs is improving and that there is room for the exchange to grow internationally. President Donald Trump paces the field at ...
This edition of the Conyers SGX & Catalist Public Companies Report summarises selected key transactions involving companies listed on the Main ...
SHARES of Singapore Exchange (SGX) fell as much as 6.3 per cent or S$0.85 to S$12.62 on Friday (Feb 14) as investors were less than impressed with the initial proposals to revive the equities market.
Regulations will also be streamlined to make the listing process more efficient ... research grant to include research coverage on pre-IPO companies and mid and small-cap enterprises.
SINGAPORE investors can now directly invest in three Hong Kong blue-chip stocks – Ping An Insurance, Meituan and Xiaomi – via ...
To support this expansion, the company plans to launch an initial public offering (IPO) on the Singapore Exchange (SGX) Catalist Board ... to manage the IPO listing process.
Nanofilm Technologies International’s S$510m (US$382m) Singapore IPO showed the city’s stock market is open ... That timetable also made it one of the quickest debuts on the SGX, completing kick-off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results